The Ministry of Health allowed the Center to them. Gamaleya to conduct clinical trials of a vaccine against COVID-19 with virus-like particles, should from the data placed in the state register of medicines.
The drug is called the VLP-corona vaccine. The purpose of the studies is to evaluate the tolerability, safety and immunogenicity of the “optimal dose of the vaccine compared with placebo for 21 days after two intramuscular injections of drugs.”
The study will involve 600 people.
The material is being added.